Abstract
Given the difficulty to find specific drugs which can treat pancreatic ductal adenocarcinoma (PDAC) efficiently, this project aims to identify molecular targets that may sensitize pancreatic cancer cells to gemcitabine. To achieve this goal and provide additional information regarding PDAC biology, this project will investigate the negative feedback mechanisms involved in MAPK signaling a…